EZH2-IN-13

CAS No. 1403255-41-3

EZH2-IN-13( —— )

Catalog No. M35760 CAS No. 1403255-41-3

EZH2-IN-13, a potent EZH2 inhibitor, exhibits potential anticancer activity and may be utilized to study diseases associated with EZH2 activity.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 235 Get Quote
10MG 377 Get Quote
25MG 725 Get Quote
50MG 1086 Get Quote
100MG 1683 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    EZH2-IN-13
  • Note
    Research use only, not for human use.
  • Brief Description
    EZH2-IN-13, a potent EZH2 inhibitor, exhibits potential anticancer activity and may be utilized to study diseases associated with EZH2 activity.
  • Description
    EZH2-IN-13 is a potent EZH2 inhibitor, for details please refer to compound 73 in patent WO2017139404. EZH2-IN-13 can be used to study cancers or precancerous lesions associated with EZH2 activity.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Histone Methyltransferase
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1403255-41-3
  • Formula Weight
    571.75
  • Molecular Formula
    C34H45N5O3
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 125 mg/mL (218.63 mM; Ultrasonic )
  • SMILES
    CCN(C1CCOCC1)c1cc(cc(C(=O)NCc2c(C)cc(C)[nH]c2=O)c1C)-c1ccc(CN2CCNCC2)cc1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Jesse Smith, et al. Methods of treating cancer. WO2017139404.
molnova catalog
related products
  • 4-Hydroxyisoleucine

    4-Hydroxyisoleucine has antidepressant-like antidyslipidemic and antihyperglycemic effects.?It displays an insulinotropic activity.

  • Escin Iia

    Escin IIa, isolated from horse chestnut, the seeds of Aesculus hippocastanum L., has positive effects on acute inflammation in animals.

  • LIT-001

    LIT-001 improves social interaction in a mouse model of autism.It is the first nonpeptide oxytocin receptor agonist with EC50 of 55 nM and Ki of 226 nM.